Seal B - Search Results

1

Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting.

Seal B, Sullivan SD, Ramsey S, Asche CV, Shermock KM, Sarma S, Zagadailov E, Farrelly E, Eaddy M. Seal B, et al. Future Oncol. 2015;11(3):439-47. doi: 10.2217/fon.14.242. Future Oncol. 2015. PMID: 25675125

2

Medical costs associated with use of systemic therapy in adults with colorectal cancer.

Seal BS, Sullivan SD, Ramsey S, Shermock KM, Ren J, Kreilick C, Foltz Boklage SH, Valluri S, Sarma S, Asche CV. Seal BS, et al. J Manag Care Pharm. 2013 Jul-Aug;19(6):461-7. doi: 10.18553/jmcp.2013.19.6.461. J Manag Care Pharm. 2013. PMID: 23806060 Free PMC article.

3

Systemic therapy for colorectal cancer: patterns of chemotherapy and biologic therapy use in nationally representative US claims database.

Seal BS, Sullivan SD, Ramsey SD, Shermock KM, Ren J, Kreilick C, Boklage S, Valluri S, Sarma S, Asche CV. Seal BS, et al. BioDrugs. 2014 Apr;28(2):229-36. doi: 10.1007/s40259-013-0073-y. BioDrugs. 2014. PMID: 24142235

4

Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.

Seal B, Sullivan SD, Ramsey SD, Asche CV, Shermock K, Sarma S, Zagadailov EA, Farrelly E, Eaddy M. Seal B, et al. Appl Health Econ Health Policy. 2014 Oct;12(5):547-57. doi: 10.1007/s40258-014-0101-1. Appl Health Econ Health Policy. 2014. PMID: 25005491 Free PMC article.

5

Efficacy, patient-reported outcomes (PROs), and tolerability of the changing therapeutic landscape in patients with metastatic prostate cancer (MPC): a systematic literature review.

Seal BS, Asche CV, Puto K, Allen PD. Seal BS, et al. Value Health. 2013 Jul-Aug;16(5):872-90. doi: 10.1016/j.jval.2013.03.1628. Epub 2013 Jul 10. Value Health. 2013. PMID: 23947983 Free article. Review.

6

Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer.

Seal BS, Anderson S, Shermock KM. Seal BS, et al. J Manag Care Spec Pharm. 2016 Mar;22(3):227-35. doi: 10.18553/jmcp.2016.22.3.227. J Manag Care Spec Pharm. 2016. PMID: 27003552 Free PMC article.

7

Evaluation of Healthcare Interventions and Big Data: Review of Associated Data Issues.

Asche CV, Seal B, Kahler KH, Oehrlein EM, Baumgartner MG. Asche CV, et al. Among authors: seal b. Pharmacoeconomics. 2017 Aug;35(8):759-765. doi: 10.1007/s40273-017-0513-5. Pharmacoeconomics. 2017. PMID: 28474299

8

Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patients.

Eaddy M, Seal B, Tangirala M, Davies EH, O'Day K. Eaddy M, et al. Among authors: seal b. Am J Health Syst Pharm. 2010 Dec 15;67(24):2110-4. doi: 10.2146/ajhp100022. Am J Health Syst Pharm. 2010. PMID: 21116002

9

Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.

Asche C, McAdam-Marx C, Seal B, Crookston B, Mullins CD. Asche C, et al. Among authors: seal b. J Antimicrob Chemother. 2008 May;61(5):1162-8. doi: 10.1093/jac/dkn073. Epub 2008 Feb 29. J Antimicrob Chemother. 2008. PMID: 18310136

10

Economic evaluations in pain management: principles and methods.

Asche CV, Seal B, Jackson KC 2nd, Oderda GM. Asche CV, et al. Among authors: seal b. J Pain Palliat Care Pharmacother. 2006;20(3):15-23. J Pain Palliat Care Pharmacother. 2006. PMID: 16931474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters